Drug intelligence / Profile preview

Cleanview-All

Development stage
Phase 3
Lead developer
Taejoon Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

CTP0301 is a low-volume (1-liter) polyethylene glycol (PEG)-based bowel preparation solution developed by Taejoon Pharmaceutical. It consists of a combination of polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid. Designed to improve patient compliance by reducing the required intake volume compared to traditional 2-liter or 4-liter PEG solutions, CTP0301 functions as an osmotic laxative. The high concentration of PEG and sodium sulfate, along with the osmotic action of the ascorbate components, induces a purgative effect by retaining water in the intestinal lumen, effectively cleansing the colon in preparation for colonoscopy. CTP0301 has been evaluated in Phase 3 clinical trials, demonstrating non-inferiority in cleansing efficacy and improved patient preference compared to standard-volume preparations.

Brand names
Cleanview-All
Other names
CTP0301CTP-0301CTP 0301Cleanview-All1L PEG-Ascorbate

Beyond the preview

Go deeper on Cleanview-All.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cleanview-All.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call